Trials / Completed
CompletedNCT01201746
Influence of Periodontal Treatment on Systemic Inflammatory Mediators
Influence of Periodontal Treatment on Systemic Inflammatory Mediators:hsC-reactive Protein, Fibrinogen and White Blood Cells in CHD Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 317 (actual)
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute · Academic / Other
- Sex
- All
- Age
- 31 Years
- Healthy volunteers
- Not accepted
Summary
Currently the research issue in establishing the role of periodontal disease (PD) in coronary heart disease (CHD) risk is to define the pathways that lead to cause-effect relationship between PD and CHD. There is no consensus on definition of a periodontal disease case or the threshold level that may give clear indication for this relationship. Periodontal therapy has been used in different studies with the hope that a change in periodontal disease status may modify the factors associated with CHD risk. Many of these studies, on role of periodontal therapy in the reduction of CHD associated risk-factors, were based on small study samples, and very few studies were randomized controlled trials. So a need for large prospective studies is warranted in literature.----------- A single-blind parallel-arm randomized controlled clinical trial was designed to observe the influence of periodontal treatment on serum inflammatory mediators of hsC-reactive protein, white blood cells and fibrinogen in CHD patients. Hypothesis: Periodontal therapy in CHD patients, by reducing periodontal inflammation, may decrease the host systemic inflammatory burden associated with atherogenic processes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Delayed treatment | Scaling, Root Planing and oral hygiene instruction |
| PROCEDURE | Periodontal therapy | Scaling, root planning and oral hygiene instructions |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2010-09-15
- Last updated
- 2016-10-14
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT01201746. Inclusion in this directory is not an endorsement.